News

All News

Find press releases issued in the past two years issued by Johnson & Johnson corporate headquarters and our operating companies.

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... 36 Next >


	Long Term Data Presented At ESC 2010 Shed Further Light on the Benefit Of The CYPHER® Sirolimus Drug-Eluting Stent Compared To The Endeavor® Zotarolimus-Eluting Stent in Important High-Risk Subgroups September 2, 2010
	Together Teens and Neutrogena Raise $200,000 to Benefit Disaster Relief, Education and Environmental Charities September 1, 2010
	CORDIS announces results of ten-year CYPHER® Sirolimus-eluting coronary stent follow-up August 31, 2010
	Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study August 31, 2010
	Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain August 30, 2010
	Johnson's® Brand Launches Johnson's® Natural™ Product Line for Babies and Kids August 26, 2010

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... 36 Next >

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2010. All Rights Reserved.